Antiviral nanoagents: More attention and effort needed?

The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongjiu, Ma, Juan, Xu, Ming, Liu, Sijin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498411/
https://www.ncbi.nlm.nih.gov/pubmed/32963581
http://dx.doi.org/10.1016/j.nantod.2020.100976
_version_ 1783583503951069184
author Chen, Yongjiu
Ma, Juan
Xu, Ming
Liu, Sijin
author_facet Chen, Yongjiu
Ma, Juan
Xu, Ming
Liu, Sijin
author_sort Chen, Yongjiu
collection PubMed
description The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomaterials, which, therefore, are considered as a significant next-generation therapeutic option. Thus, the development of novel antiviral nanoagents will certainly help address several future challenges and knowledge gaps.
format Online
Article
Text
id pubmed-7498411
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74984112020-09-18 Antiviral nanoagents: More attention and effort needed? Chen, Yongjiu Ma, Juan Xu, Ming Liu, Sijin Nano Today Article The recent COVID-19 outbreak has increasingly engaged researchers in the search for effective antiviral drugs as well as therapeutic treatment options. The shortcomings of existing antiviral agents such as narrow spectrum and low bioavailability, can be overcome through the use of engineered nanomaterials, which, therefore, are considered as a significant next-generation therapeutic option. Thus, the development of novel antiviral nanoagents will certainly help address several future challenges and knowledge gaps. Elsevier Ltd. 2020-12 2020-09-18 /pmc/articles/PMC7498411/ /pubmed/32963581 http://dx.doi.org/10.1016/j.nantod.2020.100976 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Chen, Yongjiu
Ma, Juan
Xu, Ming
Liu, Sijin
Antiviral nanoagents: More attention and effort needed?
title Antiviral nanoagents: More attention and effort needed?
title_full Antiviral nanoagents: More attention and effort needed?
title_fullStr Antiviral nanoagents: More attention and effort needed?
title_full_unstemmed Antiviral nanoagents: More attention and effort needed?
title_short Antiviral nanoagents: More attention and effort needed?
title_sort antiviral nanoagents: more attention and effort needed?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498411/
https://www.ncbi.nlm.nih.gov/pubmed/32963581
http://dx.doi.org/10.1016/j.nantod.2020.100976
work_keys_str_mv AT chenyongjiu antiviralnanoagentsmoreattentionandeffortneeded
AT majuan antiviralnanoagentsmoreattentionandeffortneeded
AT xuming antiviralnanoagentsmoreattentionandeffortneeded
AT liusijin antiviralnanoagentsmoreattentionandeffortneeded

Ejemplares similares